(i.e., failed two standard therapy courses), we conditionally recommend treatment escalation to a more intensive regimen, including addition of anti-CD20 agents, or combination therapy with three non-glucocorticoid immunosuppressives (i.e., MPAA, belimumab and CNI), or referral for investigational therapy. OTHER LUPUS KIDNEY DISEASE: GPS: Alternative etiologies of kidney dysfunction in people with SLE should be carefully excluded, including noninflammatory etiologies such as hypertensive,